Rasha Mokhtar Elnagar

Prof. Rasha Mokhtar Elnagar


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2022 in Iranian Journal of Medical Microbiology
Verified
Journal Article
Open access
PDF file
RERasha Mokhtar Elnagar
Rasha Mokhtar Elnagar
MEMohammed Elshaer
Mohammed Elshaer
OSOmar Osama Shouman
Omar Osama Shouman
SESamah Sabry El-Kazzaz
Samah Sabry El-Kazzaz
Background and Aim: Pseudomonas aeruginosa (P. aeruginosa) is an important causative organism of burn infection. Several virulence factors are implicated in P. aeruginosa colonization and invasion, making P. aeruginosa infection's outcome worse. Type III secretion system (T3SS) effector proteins are among these virulence factors. The present study evaluated the frequency of ...

14 October 2022 in Infection and Drug Resistance
Verified
Journal Article
Open access
PDF file
RERania Abd El-Hamid El-Kady
Rania Abd El-Hamid El-Kady
MEMohamed Elbaiomy
Mohamed Elbaiomy
RERasha Mokhtar Elnagar
Rasha Mokhtar Elnagar
Background: A growing body of evidence suggests that ceftazidime/avibactam (CZA) is a potential therapeutic option for carbapenem-resistant Klebsiella pneumoniae (CRKP) infections; however, resistant strains are increasingly emerged worldwide. Herein, we deemed to investigate the susceptibility profile of CRKP isolates from cancer patients to CZA and to identify the underlying resistance mechanisms. Methods: Clinical samples were obtained from adult patients admitted to the Oncology Center of Mansoura University, Mansoura, Egypt. The antibiotic susceptibility pattern of K. pneumoniae isolates to different antibiotics was tested by the modified Kirby Bauer’s disc diffusion method. Minimum inhibitory concentrations of CZA were assessed using broth microdilution method. Screening for carbapenemase-producing strains was achieved by the modified Hodge test. Multiplex polymerase chain reactions (PCRs) were conducted for uncovering of carbapenemase-encoding genes (blaKPC, blaVIM, blaIMP, blaNDM-1, and blaOXA-48), and outer membrane porin genes (ompK35 and ompK36). Results: A total of 12 CZA-resistant isolates were identified out of 47 CRKP isolates (25.5%). The MIC50 and MIC90 of CZA against CRKP were 1 and 64 μg/mL, respectively. Risk factors for CZA resistance included chronic kidney disease, mechanical ventilation, longer length of hospital stay, and ICU admission. The multivariate logistic regression demonstrated that longer length of hospital stay (P=0.03) was the only independent predictor for acquisition of CZA-resistant isolates. The leading mechanism for CZA resistance was sustained by blaKPC (50%), meanwhile 16.7% and 8.3% of the CZA-resistant isolates harbored blaOXA-48 and blaOXA-48/blaNDM-1, respectively. The MBL-encoding genes blaNDM-1 and blaIMP were detected in 16.7% and 8.3% of the isolates, respectively. Absence of both ompK35 and ompK36 was observed in 58.3% of the CZA-resistant isolates. Conclusion: CZA has displayed superior in vitro activity against CRKP isolates in comparison to other antibiotics; however, thorough molecular characterization of resistant strains is highly recommended in future studies to detect and monitor the emergence of further tackling strains.

1 October 2021 in Egyptian Journal of Medical Microbiology
Verified
Journal Article
Closed access
PDF file
RERasha Mokhtar Elnagar
Rasha Mokhtar Elnagar
Background: Onychomycosis is fungal infection of nails. Dermatophytes, Candida species, and non-dermatophyte moulds are the commonest causes of onychomycosis. Objectives: This study assessed the frequency of non-dermatophyte moulds causing onychomycosis and their antifungal susceptibility. Methodology: Our study included106 nail specimens obtained from patients attending Mansoura University Hospital from October 2019 to March 2021. All samples were examined by standard mycological methods. Results: Onychomycosis was detected in 86 nail specimens. Dermatophytes were isolated from 7 cases (6.6%), non-dermatophyte moulds from 62 cases (58.5%), Candida species from 17 cases (16.0%), and the remaining 20 cultures were negative for fungal growth. Among non-dermatophyte moulds the predominant isolates were Aspergillus fumigatus (25.5%), Aspergillus niger (17.9%), Aspergillus flavus (3.8%), Alternaria alternata (2.8%) and Penicillium species (2.8%). The non-dermatophyte moulds were highly sensitive to itraconazole and ketoconazole. Conclusion: Non-dermatophyte moulds are a common cause of onychomycosis that cause failure of therapy and should be considered in cases of onychomycosis.

1 January 2023 in Egyptian Journal of Medical Microbiology
Verified
Journal Article
Open access
PDF file
RERasha Mokhtar Elnagar
Rasha Mokhtar Elnagar
ASAmira M. Sultan
Amira M. Sultan
MAMohammad A. Ahmed
Mohammad A. Ahmed
Background: Rapid, reliable Candida species (spp.) identification is crucial because it enables prompt and effective antifungal treatment. Unfortunately this is difficult due to a lack of knowledge, adequate reagents, and equipments, particularly in countries with limited resources. Objectives: The aim of this study was to assess the effectiveness of rapid commercial methods in identifying Candida spp. isolated from critically ill patients. Methodology: Various clinical specimens were collected from critically ill patients admitted to the Intensive Care Units of Mansoura University Hospitals, and processed by numerous mycological techniques. Gram stained, and lactophenol cotton blue stained films, as well, germ tube test, and corn meal agar with 1% Tween 80 were used to identify the isolated Candida spp. Three commercial methods were used for spp. identification; CHROMagarTM Candida medium, API 20 C AUX and Vitek-2 Compact automated system. In addition, all Candida isolates were subjected to species-specific multiplex PCR as the reference method. Results: A total of 52 Candida strains were identified where C. albicans was the predominant spp. (53.8%) followed by C. parapsilolsis (17.3%), C. glabrata (13.5%), C. dubliniensis (5.8%), C. tropicalis (5.8%), C. auris (1.9%) and C. krusei (1.9%). Both CHROMagarTM Candida medium and Vitek-2 Compact automated system exhibited high sensitivity and specificity rates in identification of various Candida spp. as compared to multiplex PCR. Conclusion: This study demonstrated a good performance of both CHROMagarTM Candida medium and Vitek-2 Compact automated system; however, CHROMagarTM Candida medium may be an easier and more cost-effective choice to identify Candida spp., mainly in areas with restricted resources.

1 October 2022 in Egyptian Journal of Medical Microbiology
Verified
Journal Article
Closed access
PDF file
RERasha Mokhtar Elnagar
Rasha Mokhtar Elnagar
RMRasha Mahmoud
Rasha Mahmoud
RERania El-Kady
Rania El-Kady
Background: In recent years, emergence of linezolid-resistant strains has gained a considerable clinical concern. Tedizolid, a relatively new antibiotic, showed strong effectiveness against S. aureus; however, few data are available from Egypt in this regard. Objectives: This study aimed to assess the in vitro susceptibility of S. aureus clinical isolates from Mansoura University Hospitals (MUHs), Egypt to linezolid and tedizolid, and to unveil the underlying molecular mechanisms for resistance. Methodology: In vitro susceptibility of 113 S. aureus isolates from various clinical samples was determined by disc diffusion method. The broth microdilution method was used to determine the MICs of linezolid and tedizolid. Detection of mecA and cfr genes among MRSA and linezolid-resistant isolates, respectively was performed using polymerase chain reaction (PCR). Results: In this study, 16.8% of S. aureus isolates were methicillin-resistant. On the other hand, resistance to vancomycin and linezolid was identified in 15%, and 9.7 % of the isolates, respectively. All the isolates were susceptible to tedizolid. In comparison between methicillin-sensitive S. aureus (MSSA) and MRSA as regards tedizolid and linezolid susceptibility, tedizolid retained low MIC50, and MIC90 (0.25, and 0.5 µg/L) for all S. aureus isolates. On the other hand, the MICs of linezolid were 0.5–2 µg/L for MSSA, and 0.5–>4 µg/L for MRSA isolates. All MRSA isolates (n= 19) were found to harbor the mecA gene. The cfr gene was identified in 57.9% of linezolid-resistant MRSA isolates. Conclusion: Tedizolid is highly effective against S. aureus clinical isolates, including linezolid-resistant strains.

6 December 2022 in Egyptian Journal of Botany
Verified
Journal Article
Closed access
RERasha Mokhtar Elnagar
Rasha Mokhtar Elnagar
MEMohammed Elshaer
Mohammed Elshaer
MEMona A. Abd El-Raouf
Mona A. Abd El-Raouf
The resistance of Candida to antifungal agents is an emerging global health problem, especially with the emergence of new species. Therefore, the focus has shifted to alternative agents like silver nanoparticles (AgNPs), received significant attention. The aim of this study was to evaluate the in vitro antifungal susceptibility of AgNPs against resistant Candida isolates from various clinical specimens. The antifungal effect of AgNPs was assessed by the broth microdilution method using different concentrations (0.062-1 µg/mL). The Minimum Inhibitory Concentration (MIC50) and Minimum Fungicidal Concentration (MFC) of AgNPs were determined. As a result, of 109 recovered Candida isolates, 65.1%, and 34.9% were C. albicans andnon-albicans Candida (NAC), respectively. Moreover, 35.8% of the Candida isolates were non-susceptible to conventional antifungal drugs. The MIC50 of AgNPs against resistant isolates was lower (0.125-1 µg/mL) than that of fluconazole (1-64 µg/mL), itraconazole (0.016-4 µg/mL), voriconazole (0.016-4 µg/mL), and amphotericin B (0.016-1 µg/mL). The scanning electron micrograph revealed that AgNPs treatment alteredthe cell morphology of Candida. In conclusion, AgNPs exhibited a notable fungicidal effect against resistant Candida isolates and may be an adequate substitute for antifungal agents.